U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT07451171) titled 'Comparative Efficacy of Antibiotics for Small Intestine Bacterial Overgrowth in Bangladeshi Children' on Feb. 27.
Brief Summary: The purpose of this Phase IIa study is to identify the most effective antibiotic regimen to treat small intestine bacterial overgrowth (SIBO) in impoverished Bangladeshi children.
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Small Intestine Bacterial Overgrowth
Intervention:
DRUG: Trimethoprim-sulfamethoxazole (TMP/SMX)
8-10 mg/kg/day divided every 12 hours, with a maximum 160 mg/dose; dosing based on Trimethoprim
DRUG: Metronidazole
Administered alone: 20-30 mg/kg/day divid...